Effect of Nocturnal Oxygen on Blood Pressure Response to Altitude Exposure in COPD – Data from a Randomized Placebo-Controlled Cross-Over Trial

References

• Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05.020415
   PubMed Web of Science ®Google Scholar
• Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):543–548. doi:10.1513/pats.200708-142ET
   PubMedGoogle Scholar
• Hansen J, Sander M. Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol. 2003;546(Pt 3):921–929. doi:10.1113/jphysiol.2002.031765
   PubMed Web of Science ®Google Scholar
• Chapleau MW. Determinants of baroreflex sensitivity in health and disease: from correlates to causality. Clin Auton Res. 2003;13(5):310–313. doi:10.1007/s10286-003-0131-5
   PubMed Web of Science ®Google Scholar
• Cowley AW Jr., Liard JF, Guyton AC. Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res. 1973;32(5):564–576. doi:10.1161/01.RES.32.5.564
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol. 2008;13(2):191–207. doi:10.1111/j.1542-474X.2008.00219.x
   PubMed Web of Science ®Google Scholar
• La Rovere MT, Bigger JT Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Lancet. 1998;351(9101):478–484. doi:10.1016/S0140-6736(97)11144-8
   PubMed Web of Science ®Google Scholar
• Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation. 1982;66(4):874–880. doi:10.1161/01.CIR.66.4.874
   PubMed Web of Science ®Google Scholar
• Andreas S, Haarmann H, Klarner S, Hasenfuss G, Raupach T. Increased sympathetic nerve activity in COPD is associated with morbidity and mortality. Lung. 2014;192(2):235–241. doi:10.1007/s00408-013-9544-7
   PubMed Web of Science ®Google Scholar
• Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest. 1994;106(5):1432–1437. doi:10.1378/chest.106.5.1432
   PubMed Web of Science ®Google Scholar
• Bartels MN, Gonzalez JM, Kim W, De Meersman RE. Oxygen supplementation and cardiac-autonomic modulation in COPD. Chest. 2000;118(3):691–696. doi:10.1378/chest.118.3.691
   PubMed Web of Science ®Google Scholar
• Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-6
   PubMed Web of Science ®Google Scholar
• Patakas D, Louridas G, Kakavelas E. Reduced baroreceptor sensitivity in patients with chronic obstructive pulmonary disease. Thorax. 1982;37(4):292–295. doi:10.1136/thx.37.4.292
   PubMed Web of Science ®Google Scholar
• Schwarz EI, Latshang TD, Furian M, et al. Blood pressure response to exposure to moderate altitude in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:659–666. doi:10.2147/COPD.S194426
   PubMed Web of Science ®Google Scholar
• Graham WG, Houston CS. Short-term adaptation to moderate altitude. Patients with chronic obstructive pulmonary disease. JAMA. 1978;240(14):1491–1494. doi:10.1001/jama.1978.03290140033017
   PubMed Web of Science ®Google Scholar
• Stream JO, Luks AM, Grissom CK. Lung disease at high altitude. Expert Rev Respir Med. 2009;3(6):635–650. doi:10.1586/ers.09.51
   PubMedGoogle Scholar
• Furian M, Hartmann SE, Latshang TD, et al. Exercise performance of lowlanders with COPD at 2590 m: data from a randomized trial. Respiration. 2018;95(6):422–432. doi:10.1159/000486450
   PubMedGoogle Scholar
• Furian M, Flueck D, Latshang TD, et al. Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trial. Int J Chron Obstruct Pulmon Dis. 2018;13:3529–3538. doi:10.2147/COPD.S173039
   PubMed Web of Science ®Google Scholar
• Somers VK, Mark AL, Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest. 1991;87(6):1953–1957. doi:10.1172/JCI115221
   PubMed Web of Science ®Google Scholar
• Parati G, Agostoni P, Basnyat B, et al. Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: a joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine. Eur Heart J. 2018;39(17):1546–1554. doi:10.1093/eurheartj/ehx720
   PubMed Web of Science ®Google Scholar
• Hasler ED, Saxer S, Schneider SR, et al. Effect of breathing oxygen-enriched air on exercise performance in patients with Chronic Obstructive Pulmonary Disease: randomized, placebo-controlled, cross-over trial. Respiration. 2020;99(3):213–224. doi:10.1159/000505819
   PubMed Web of Science ®Google Scholar
• Lacasse Y, Series F, Corbeil F, et al. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2020;383(12):1129–1138. doi:10.1056/NEJMoa2013219
   PubMed Web of Science ®Google Scholar
• Cranston JM, Crockett AJ, Moss JR, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;4:CD001744. doi:10.1002/14651858.CD001744.pub2
   PubMed Web of Science ®Google Scholar
• Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3):391–398. doi:10.7326/0003-4819-93-3-391
   PubMed Web of Science ®Google Scholar
• Stuart H, Harris S, Tjh C. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the medical research council working party. Lancet. 1981;1(8222):681–686.
   PubMed Web of Science ®Google Scholar
• Tan L, Latshang TD, Aeschbacher SS, et al. Effect of nocturnal oxygen therapy on nocturnal hypoxemia and sleep apnea among patients with Chronic Obstructive Pulmonary Disease traveling to 2048 meters: a randomized clinical trial. JAMA Netw Open. 2020;3(6):e207940. doi:10.1001/jamanetworkopen.2020.7940
   PubMed Web of Science ®Google Scholar
• Di Rienzo M, Castiglioni P, Parati G. The sequence technique revised: additional concepts on the assessment of spontaneous baroreflex function. Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:1703–1705. doi:10.1109/IEMBS.2010.5626844
   PubMedGoogle Scholar
• Mozer MT, Holbein WW, Joyner MJ, Curry TB, Limberg JK. Reductions in carotid chemoreceptor activity with low-dose dopamine improves baroreflex control of heart rate during hypoxia in humans. Physiol Rep. 2016;4(13):e12859. doi:10.14814/phy2.12859
   PubMedGoogle Scholar
• Querido JS, Wehrwein EA, Hart EC, Charkoudian N, Henderson WR, Sheel AW. Baroreflex control of muscle sympathetic nerve activity as a mechanism for persistent sympathoexcitation following acute hypoxia in humans. Am J Physiol Regul Integr Comp Physiol. 2011;301(6):R1779–R1785. doi:10.1152/ajpregu.00182.2011
   PubMed Web of Science ®Google Scholar
• Bernardi L, Passino C, Spadacini G, et al. Cardiovascular autonomic modulation and activity of carotid baroreceptors at altitude. Clin Sci. 1998;95(5):565–573. doi:10.1042/cs0950565
   Web of Science ®Google Scholar
• Bourdillon N, Yazdani S, Subudhi AW, et al. AltitudeOmics: baroreflex sensitivity during acclimatization to 5260 m. Front Physiol. 2018;9:767. doi:10.3389/fphys.2018.00767
   PubMed Web of Science ®Google Scholar
• Van De Borne P, Mezzetti S, Montano N, Narkiewicz K, Degaute JP, Somers VK. Hyperventilation alters arterial baroreflex control of heart rate and muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol. 2000;279(2):H536–541. doi:10.1152/ajpheart.2000.279.2.H536
   PubMed Web of Science ®Google Scholar
• Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32(5):1371–1385. doi:10.1183/09031936.00015608
   PubMed Web of Science ®Google Scholar
• Hubloue I, Rondelet B, Kerbaul F, et al. Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs. Crit Care. 2004;8(4):R163–171. doi:10.1186/cc2860
   PubMed Web of Science ®Google Scholar
• Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262(6 Pt 1):E763–778. doi:10.1152/ajpendo.1992.262.6.E763
   PubMedGoogle Scholar
• Averill DB, Diz DI. Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull. 2000;51(2):119–128. doi:10.1016/S0361-9230(99)00237-3
   PubMed Web of Science ®Google Scholar
• Swierblewska E, Hering D, Kara T, et al. An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens. 2010;28(5):979–984. doi:10.1097/HJH.0b013e328336ed9a
   PubMed Web of Science ®Google Scholar
• McAllister DA, Maclay JD, Mills NL, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(12):1208–1214. doi:10.1164/rccm.200707-1080OC
   PubMed Web of Science ®Google Scholar
• Schillaci G, Bilo G, Pucci G, et al. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension. 2012;60(2):369–377. doi:10.1161/HYPERTENSIONAHA.112.197491
   PubMed Web of Science ®Google Scholar
• McNicholas WT. Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease. J Thorac Dis. 2018;10(Suppl 34):S4253–S4261. doi:10.21037/jtd.2018.10.117
   PubMedGoogle Scholar
• Lewis CA, Fergusson W, Eaton T, Zeng I, Kolbe J. Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax. 2009;64(2):133–138. doi:10.1136/thx.2007.088930
   PubMed Web of Science ®Google Scholar
• Fletcher EC, Luckett RA, Goodnight-White S, Miller CC, Qian W, Costarangos-Galarza C. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis. 1992;145(5):1070–1076. doi:10.1164/ajrccm/145.5.1070
   PubMed Web of Science ®Google Scholar
• Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999;14(5):1002. doi:10.1183/09031936.99.14510029
   PubMed Web of Science ®Google Scholar
• Orth M, Walther JW, Yalzin S, et al. [Influence of nocturnal oxygen therapy on quality of life in patients with COPD and isolated sleep-related hypoxemia: a prospective, placebo-controlled cross-over trial]. Pneumologie. 2008;62(1):11–16. German. doi:10.1055/s-2007-980129
   PubMedGoogle Scholar
• Yazdani S, Bourdillon N, AltitudeOmics G, Vesin J-M AltitudeOmics: effect of exercise on baroreflex sensitivity at sea level and altitude; 2016.
   Google Scholar
• Tank J, Baevski RM, Fender A, et al. Reference values of indices of spontaneous baroreceptor reflex sensitivity. Am J Hypertens. 2000;13(3):268–275. doi:10.1016/S0895-7061(99)00172-7
   PubMed Web of Science ®Google Scholar